New blood filter may shield heart surgery patients from organ failure
NCT ID NCT07532174
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a device called Efferon LPS that filters harmful substances from the blood during and after heart surgery. The goal is to see if it can reduce the risk of multiple organ failure, a serious complication. Researchers will enroll 60 adults having heart surgery with a heart-lung machine. The device is used twice: once during surgery and once within 24 hours after.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Efferon LPS device (blood filter cartridge that removes toxins and inflammatory substances)
What this could lead to
If it works, this device could lower the chance of multiple organ failure after heart surgery, helping patients recover better.
What could go wrong
This is a small early study with only 60 patients, so results may not apply to everyone. The device adds extra steps to surgery and could have unknown side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Almazov National Medical Research Centre
RECRUITINGSaint Petersburg, Russia
Contact Email: •••••@•••••
-
Pavlov First Saint Petersburg State Medical University
RECRUITINGSaint Petersburg, Russia
Contact Email: •••••@•••••
-
Regional State Budgetary Healthcare Institution "Altai Regional Cardiological Dispensary"
RECRUITINGBarnaul, Russia
Contact Email: •••••@•••••